Hamilton Thomas Edward — SEC insider filings

SEC reporting owner CIK 1769848. 19 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2020-09-30 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Larimar Therapeutics, Inc. (LRMR)Director126 legs · 651,378 sh · $2,850,181—7
ANNALY CAPITAL MANAGEMENT INC (NLY)Director7—1 leg · 80,000 sh · $734,4326

Insider filings — Hamilton Thomas Edward

FiledFormIssuerReported transactionsSource
2026-11-124Larimar Therapeutics, Inc. (LRMR)Purchase (P): 70,000 @ $2.67EDGAR
2026-07-084Larimar Therapeutics, Inc. (LRMR)Purchase (P): 50,000 @ $3.34EDGAR
2026-06-124ANNALY CAPITAL MANAGEMENT INC (NLY)Grant/award (A): 8,641 (derivative) @ $0EDGAR
2026-05-204Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 55,150 (derivative) @ $0EDGAR
2026-03-024Larimar Therapeutics, Inc. (LRMR)Purchase (P): 100,000 @ $5EDGAR
2025-05-154ANNALY CAPITAL MANAGEMENT INC (NLY)Grant/award (A): 8,961 (derivative) @ $0EDGAR
2025-05-144Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2024-05-314Larimar Therapeutics, Inc. (LRMR)Purchase (P): 57,208 @ $8.74 · Grant/award (A): 19,000 (derivative) @ $0EDGAR
2024-05-174ANNALY CAPITAL MANAGEMENT INC (NLY)Grant/award (A): 8,583 (derivative) @ $0EDGAR
2023-05-194ANNALY CAPITAL MANAGEMENT INC (NLY)Grant/award (A): 8,167 (derivative) @ $0EDGAR
2023-05-114Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 8,300 (derivative) @ $0EDGAR
2022-09-204Larimar Therapeutics, Inc. (LRMR)Purchase (P): 317,460 @ $3.15EDGAR
2022-05-204ANNALY CAPITAL MANAGEMENT INC (NLY)Grant/award (A): 24,372 (derivative) @ $0EDGAR
2022-05-124Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 8,300 (derivative) @ $0EDGAR
2021-07-024Larimar Therapeutics, Inc. (LRMR)Purchase (P): 56,710 @ $8.75EDGAR
2021-05-214ANNALY CAPITAL MANAGEMENT INC (NLY)Grant/award (A): 15,609 (derivative) @ $0EDGAR
2021-05-174Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 8,300 (derivative) @ $0EDGAR
2021-05-044ANNALY CAPITAL MANAGEMENT INC (NLY)Sale (S): 80,000 @ $9.18EDGAR
2020-09-304Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 16,600 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1769848 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs